What are the Treatment Options for Translocation-Related Cancers?
Treatment strategies for cancers involving translocations often include targeted therapies designed to inhibit the activity of fusion proteins. For instance, tyrosine kinase inhibitors (TKIs) like imatinib are used to treat CML patients with the BCR-ABL fusion gene. Other treatment options may include chemotherapy, radiation therapy, and in some cases, bone marrow transplantation.
